10.07.2015 Views

Format of Forwarding Letter

Format of Forwarding Letter

Format of Forwarding Letter

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

GOVERNMENT OF INDIAOFFICE OF THE ADDL. D.G. & MEDICAL SUPERINTENDENTV.M.M.C. & SAFDARJANG HOSPITALNEW DELHI-110029No. : Q-1-MS(1to 10)/2012-TENDER NOTICEAddl. D.G. & M.S. Safdarjang Hospital, New Delhi invites tenders in sealed envelopefor the procurement <strong>of</strong> drugs/Medicines <strong>of</strong> the following groups for S.J. Hospital & Dr.R.M.L. Hospital, New Delhi from the eligible firms, preferably manufacturers.Sn. Q-1-MS(no)1. Q-1-MS(10)Group Medicines / drugs Date <strong>of</strong> Tender Time <strong>of</strong>opening openingI Miscellaneous 30/05/2012 10.30 amELIGIBILITY CRITERIA1. EMD: a) Earnest money deposit <strong>of</strong> `1,00,000.00 (Rupees One lakh only) for each groupexcept <strong>of</strong> group I, and `25,000.00 (Rupees Twenty Five Thousand only) for group I, inthe shape <strong>of</strong> Demand Draft only, drawn in favour <strong>of</strong> the Medical Superintendent,Safdarjang Hospital, New Delhi should be attached with the tender form, failing whichthe tender will be rejected. b) The Tender Number, due date and complete address <strong>of</strong> thefirm should also be written on the back <strong>of</strong> the demand draft.2. DRUG LICENSE: A valid drug license / import License from the drug controller forthe manufacture /Import <strong>of</strong> the medicine/drug quoted. If revalidation <strong>of</strong> drug license hasbeen applied for the copy <strong>of</strong> application to State Drug / Licensing authority may beattached with a certificate that application for renewal was made within time frame asper Drug and Cosmetic Act as amended up to date and that has not been deleted bylicensing authority3. QUALITY: a) Manufacturing firms should be registered with the Directorate General <strong>of</strong>Quality Assurance (D.G.Q.A.), or should have Good Manufacturing Practice (G.M.P.)certificate as per Revised Schedule ‘M’ <strong>of</strong> Drugs & Cosmetic Act for indigenous drugs.b) For imported drugs, good manufacturing practice (G.M.P) certificate verified by theState Drug Controller / Drug Controller <strong>of</strong> India. In accordance with the W.H.O.recommendations (in short called WHO – GMP Certificate) should be furnished for thedrug/medicine quoted.4. EXPERIENCE: The bidder should have not less than 2 years <strong>of</strong> manufacturing andmarketing experience for the specified product duly supported by documentary evidenceexcept in case <strong>of</strong> new drugs5. ANNUAL TURNOVER: The Manufacturing firms should have minimum annualturnover <strong>of</strong> :a. `50 crores (Fifty crore) for GROUP A -1( higher antibiotics)b. `12 crore (Twelve crores) for GROUP A-2, B, C, D, E, F, G and H (bloodproducts and other items except Misc. Drugs),c. `5 crores (Five crores) for Group-IA complete set <strong>of</strong> Tender documents including terms and conditions along with list <strong>of</strong>


drugs/medicines for each group can be obtained from the Medical store Deptt. SafdarjangHospital, New Delhi on written request and on cash payment <strong>of</strong> `500/- (Five HundredRupees only) in Accounts Department for each group/tender (Non-refundable), on anyworking day between 10.00 AM and 1.00 PM and on Saturdays up to 12.00 Noon. TheTender can also be downloaded from hospital website www.vmmc-sjh.nic.in and in such casetenderer has to enclose along with tender DD/Pay Order a sum <strong>of</strong> `500/- (Five hundred only)drawn in favour <strong>of</strong> Addl. DG & MS, Safdarjang Hospital, New Delhi payable at New Delhi.The tender documents are non - transferrableManufacturing firms or authorized distributors should submit their bids in TWOPARTS i.e. Techno-commercial bid and Price Bid as detailed in the terms and conditions,in separate sealed envelope. Tenders under sealed Cover should be dropped into the Tenderbox kept in Addl. DG & MS Office block, Safdarjang hospital, ND. Our reference number <strong>of</strong>each tender and date <strong>of</strong> opening should be mentioned on the top <strong>of</strong> Sealed Envelope. Tenderswill be opened on scheduled date and time in the presence <strong>of</strong> participating tenderers. If incase, the date <strong>of</strong> opening falls on a public holiday, the same will be opened on the nextworking day at 10.00 a.m.Bidders are requested to watch for any modifications / corrigendum in thewebsite.Please read the terms and conditions carefully before filling the tender forms.Addl. DG & MS, Safdarjang Hospital, New Delhi reserves the right at his discretionto accept or reject any tender at any stage in part or the full, without assigning any reasonwhatsoever.Sd/-S. A. G. Officer / C.M.O. (Stores)For Addl. D.G. & M.S. Medical Store


<strong>Format</strong> <strong>of</strong> <strong>Forwarding</strong> <strong>Letter</strong>FORWARDING LETTER(To be filled in by the tendering party in <strong>of</strong>ficial letter head)The Medical Superintendent,Safdarjang Hospital,New Delhi-110029Tender Enquiry No. & date: Q-1-MS(10) 30/05/2012Date & Time <strong>of</strong> opening <strong>of</strong> tender: 30/05/2012 … 10.30 amGroup <strong>of</strong> Medicine for Which Quoted : I (Miscellaneous)Sir,With reference to the above Tender Enquiry I/We are submitting herewith our tender documents……….The tender document is duly paginated and contains from page No 1 to… … … …A checklist chronologically indicating documents attached in original/copies duly attested by Gazetted Officeras per Clause 22 <strong>of</strong> tender document is also enclosed.CHECKLISTS.No. DOCUMENTS ENCLOSED YES/NO PAGENO.1 EMD for Rs.25,000 /-2 Valid Drug License/Import license for quoted medicine/drug3 Valid DGQA/Revised Schedule ‘M’/WHO GMP certificates4 The bidder should have not less than 2 years <strong>of</strong> manufacturing andmarketing experience for the specified product duly supported bydocumentary evidence except in case <strong>of</strong> new drugs5 Copy <strong>of</strong> up to date returns/acknowledgement from the department <strong>of</strong> trade& taxes with TIN No.6 Certificate to the effect that all the terms & conditions mentioned in thetender document are acceptable as per Clause 2 (ii) <strong>of</strong> tender document7 Latest Audited Balance Sheet <strong>of</strong> Manufacturing Firm (Annual Turn overfor the last year)8 Latest certificate <strong>of</strong> authorization from the manufacturer for the quoteddrugs/medicines valid at least for one year9 Latest certificate regarding the blood products being free from HIV, HBV& HCV viruses10 Undertaking from the firm to supply the quoted drugs/medicines withinthe stipulated time period11 Affidavit regarding the non blacklisting <strong>of</strong> the firm or any <strong>of</strong> its productsby any Central / State Govt organisation.12 Certificate issued by Central/State Drug Controller/Licensing Authority incase newly introduced medicines/drugs13 S<strong>of</strong>t copy <strong>of</strong> the documents in the form <strong>of</strong> CD14 Undertaking to replace the defective items if any at the cost <strong>of</strong> supplier15 Receipt <strong>of</strong> purchase <strong>of</strong> tender document (for Rs.500=00)16 Alphabetical Index <strong>of</strong> drugs quoted in the present tender together withpage no.(s) <strong>of</strong> Drug Licence, Schedule M or WHO GMP Certificate andmarketing & manufacturing certificates.Name (s) and Signature (s) <strong>of</strong> the tenderer with stamp <strong>of</strong> the firm


GOVERNMENT OF INDIAOFFICE OF THE MEDICAL SUPERINTENDENTSAFDARJANG HOSPITAL, NEW DELHI-110029Rate enquiry for Safdarjang Hospital, New Delhi / Dr. R.M.L. Hospital, New DelhiPrice <strong>of</strong> Form Rs.500/- (Per Group)ADVERTISED TENDER ENQUIRYTENDER NO & DATE : Q-1-MS(10) dt. 30/05/2012BRIEF DESCRIPTION OF ITEMS (Group) : I ( Miscellaneous )TIME & DATE OF OPENING OF TENDER : 30//05/2012 … 10.30 amAMOUNT OF BID SECURITY : Rs. 25,000-00 ( Rupees Twenty Five Thousand only )T E R M S A N D C O N D I T I O N SOnly those firms will qualify to compete, who meet the following eligibility criteria1. ELIGIBILITY CRITERIAi. EMD: Earnest money deposit <strong>of</strong> Rs. 1,00,000.00 (Rupees One lakh only) for each group exceptGroup I, and Rs. 25,00.00 for group I, in the shape <strong>of</strong> Demand Draft only, drawn in favour <strong>of</strong> theMedical Superintendent, Safdarjang Hospital, New Delhi should be attached with the tender form,failing which the tender will be rejected. The Tender Number, due date and complete address <strong>of</strong>the firm should also be written on the back <strong>of</strong> the demand draft.ii. DRUG LICENSE: A valid drug license / import License from the drug controller for themanufacture /Import <strong>of</strong> the medicine/drug quoted. A valid drug license / import License from thedrug controller for the manufacture /Import <strong>of</strong> the medicine/drug quoted. If revalidation <strong>of</strong> druglicense has been applied for the copy <strong>of</strong> application to State Drug / Licensing authority may beattached with a certificate that application for renewal was made within time frame as per Drugand Cosmetic Act as amended up to date and that has not been deleted by licensing authorityiii. QUALITY: Manufacturing firms should be registered with the Directorate General <strong>of</strong> QualityAssurance (D.G.Q.A.), or should have Good Manufacturing Practice (G.M.P.) certificate as perRevised Schedule ‘M’ <strong>of</strong> Drugs & Cosmetic Act for indigenous drugs. For imported drugs, goodmanufacturing practice (G.M.P) certificate verified by the State Drug Controller / Drug Controller<strong>of</strong> India. In accordance with the W.H.O. recommendations (in short called WHO – GMPCertificate) should be furnished for the drug/medicine quoted.The firm should clearly highlight the quoted item(s) in the list <strong>of</strong> DGQA / WHO-GMP certificates& Drug license.iv. EXPERIENCE: The bidder should have not less than 2 years <strong>of</strong> manufacturing and marketingexperience for the specified product duly supported by documentary evidence except in case <strong>of</strong>new drugs.v. ANNUAL TURNOVER: The Manufacturing firms should have minimum annual turnover <strong>of</strong> :a. Rs. 50 crores (Fifty crore) for GROUP A -1( higher antibiotics)b. Rs 12 crore (Twelve crores) for GROUP A-2, B, C, D, E, F, G and H (blood products andother items except Misc. Drugs),c. Rs 5 crores (Five crores) for Group-I(The annual audited Balance Sheet <strong>of</strong> the manufacturing firm for the last financial year should beenclosed in all cases).2. SUBMISSION OF BIDSi. The bidders shall submit their bids in two parts in separate sealed covers marked as a)“TECHNO-COMMERCIAL BID” b) “PRICE BID” as the case may be. Both the sealedenvelopes should also have the Tender No., Date <strong>of</strong> Opening, Group <strong>of</strong> Items, name & address<strong>of</strong> the bidder, marked on the sealed envelopes. Both the sealed envelopes should be put in anouter Main Cover which should also be sealed and marked with Tender No., Date <strong>of</strong> Opening,Group <strong>of</strong> Items, name & address <strong>of</strong> the bidder.


ii. TECHNO – COMMERCIAL BID : All the documents as mentioned in the EligibilityCriteria, Clause 22 <strong>of</strong> the terms & conditions and check list (enclosed), any other documentwhich doesn’t give an indication <strong>of</strong> the price, List <strong>of</strong> items quoted with specifications /composition <strong>of</strong> the item, pack size etc. should be enclosed in the Techno-Commercial Bid.(THE COLUMN FOR PRICE SHOULD BE LEFT BLANK IN TECHNO – COMMERCIALBID). If price is mentioned in the techno-commercial bid, the bid is likely to be rejected. Thebid should be duly type written, free from erasing/over-writing/cuttings along with a s<strong>of</strong>t copy<strong>of</strong> the same in non convertible PDF format.iii. PRICE BID: List <strong>of</strong> items quoted with specifications / composition <strong>of</strong> the item, pack size etcexactly as submitted in the Techno-commercial bid along with the price <strong>of</strong> the items should beenclosed in the Price Bid (in duplicate). It should be duly type written, free from erasing/overwriting/cuttingsalong with a s<strong>of</strong>t copy <strong>of</strong> the same in non convertible PDF format. The rateswill be valid for a period <strong>of</strong> not less than one year or till new tenders are finalized for nextfinancial year which ever is lateriv. It may be noted that when the main cover is opened on the date and time scheduled for bidopening, only the technical bids will be opened and read out in public.v. Bidders whose techno-commercial bids are found substantially responsive will be informed <strong>of</strong>the date and time <strong>of</strong> opening <strong>of</strong> their price bids. Price bids <strong>of</strong> others will be returned to themunopened before, opening the price bids <strong>of</strong> others. If some <strong>of</strong> the items <strong>of</strong> a bidder aretechnically approved, the price <strong>of</strong> other items which are not approved shall be ignoredvi. The documents should be dropped in the tender box kept at the Ground Floor in Addl D.G.and Medical Superintendents Office, before the date and time <strong>of</strong> the Tender Opening.vii. All the pages <strong>of</strong> tender documents should be properly numbered and total number <strong>of</strong>pages be indicated on the forwarding letter as per format attached.viii. For newly introduced drugs, the manufacturer will be required to submit a certificate <strong>of</strong>marketing from the Central / State Drug Controller / Licensing Authority3. UNDERTAKINGi. The firms should give an undertaking that they are bound to supply the quotedmedicines/drugs within the stipulated time, failure <strong>of</strong> which would render the firm liable foraction as mentioned in clause 15 (i) <strong>of</strong> the tender.ii. The firm is required to submit a certificate in the format as “I / we have read and understoodall the terms and conditions governing the tender. I / we agree to abide by all the terms andconditions <strong>of</strong> the tender enquiry”4. BID OPENINGi. The Tender Opening Committee (TOC) will open bids in the presence <strong>of</strong> bidder’srepresentative, who choose to intend, at the time and date specified in the invitation for bidsand in the following location.OFFICE OF THE MEDICAL SUPERINTENDENTSAFDARJANG HOSPITALNEW DELHI-110029ii.iii.The bidders representatives who choose to attend the bid opening, shall bring with them aletter <strong>of</strong> authority from the bidder on the letter head for having been authorized to be presentat the time <strong>of</strong> opening <strong>of</strong> the bid. In the absence <strong>of</strong> such a a letter <strong>of</strong> authority, therepresentative will not be allowed to present and/or to attend the bid opening. The bidder’srepresentatives who are present shall sign a register evidencing their attendance. In the event<strong>of</strong> the specified date <strong>of</strong> bid <strong>of</strong> opening being declared a holiday for the purchaser the bids shallbe opened at the appointed time and location on the next working day.The TOC will examine the bids to determine whether they are complete, whether required bidsecurity has been furnished, whether the documents have been properly signed, and whetherthe bids are generally in order.


5. TECHNO-COMMERCIAL AND PRICE EVALUATIONi. The constituted Joint Purchase Committee (JPC), on behalf <strong>of</strong> the purchaser shall determinethe substantial responsiveness <strong>of</strong> each bid in accordance with the terms & conditions <strong>of</strong> thebidding documents. For purposes <strong>of</strong> these clauses, a substantially responsive bid is one,which conforms to all the terms and conditions <strong>of</strong> the bidding documents without materialdeviations.ii. The Committee may waive any minor informality or non-conformity or irregularity in a bid,which does not constitute a material deviation, provided such waiver does not prejudice oraffect the relative ranking <strong>of</strong> any bidder.iii. The Committee’s determination as to the substantial responsiveness or otherwise on each bidiv.or consideration <strong>of</strong> a minor informality or non-conformity or regularity is final and conclusive.The Price bid <strong>of</strong> only techno-commercially responsive bids/items shall be evaluated by theJPC after opening <strong>of</strong> the price bids.v. Arithmetical errors will be rectified on the following basis. If there is a discrepancy betweenthe unit price and quantity, the unit price shall prevail and the total price shall be corrected. Ifthe supplier does not accept the correction <strong>of</strong> the errors, its bids will be rejected. If there is adiscrepancy between the words and <strong>of</strong> figures the amount in words shall prevail.6. The stores <strong>of</strong>fered should comply with the provisions <strong>of</strong> the Drug Control Act 1940 and the rulesamended from time to time.7. (i) The manufacturer should preferably participate in the tenders directly. If the bids are submitted throughan authorised distributor, a valid certificate <strong>of</strong> authorisation, valid for at least one year, should beobtained from the manufacturer. In case the authorised distributor is quoting, all the certificates asrequired in the terms and conditions <strong>of</strong> tender should be from the manufacturer with their responsibilityand liability. In case the name <strong>of</strong> the authorised distributor is changed by the manufacturer, acceptance<strong>of</strong> the new authorised distributor for supply <strong>of</strong> drugs shall be at sole discretion <strong>of</strong> the hospital authorityand the onus <strong>of</strong> the responsibility would lie with the manufacturer.(ii) The authorised distributor, quoting for a specific item / drug, shall quote the rates <strong>of</strong> only onemanufacturer in one tender.8. (i) It will be a condition on the approval <strong>of</strong> the <strong>of</strong>fer that the price charged for the stores supplied to thehospital shall in no event exceed the lowest at which the tenderer sells the stores <strong>of</strong> identicaldescription to any other individual / Govt or private institution. Violation <strong>of</strong> this clause will entaildebarring the erring firm from participating in the tender for two consecutive years.(ii) If at any stage during the tenure <strong>of</strong> the tender, the tenderer reduces the sales price lower than the pricecharged under the agreement, the tenderer will forthwith notify such reductions <strong>of</strong> the sale price to theMedical Superintendents <strong>of</strong> Safdarjang Hospital and Dr. R. M. L. Hospital, New Delhi.(iii) The quoted prices should not be in excess <strong>of</strong> Drug Control Order 1970, and the rules made thereafter asamended from time to time.9 (i) The rates should be quoted strictly as per our specification and per unit as mentioned in the list <strong>of</strong>drugs and supplied accordingly, e.g. in strips <strong>of</strong> 10 etc.(ii) The pack size and pack size rates should be specifically mentioned and adhered to while supplying thematerial.(iii) The rates <strong>of</strong> Tablets / Capsules should be quoted in strip pack only, mentioning pack size.(iv) Drug inserts/product inserts which are invariably supplied by the manufacturer/distributor with theproduct at the sale counter/or product brochure must be attached as enclosures with this tender.10. The quantity shown in the schedule is an estimated requirement and it cannot be guaranteed that thesame will be ordered.11. Excise duty(ED), Central Tax(CT), Sales Tax(ST) and other taxes, if chargeable extra, where legallylevied and intended to be claimed, should be distinctly shown along with the quoted price and no suchclaim if any, will be admitted at any later stage on any grounds. However, in the event <strong>of</strong> any revisionin the existing rates <strong>of</strong> duties or introduction <strong>of</strong> any statutory duty and taxes imposed by the Govt., thesame will be paid extra on production <strong>of</strong> satisfactory documentary pro<strong>of</strong>.


12. No facility regarding CDEC/import license etc. can be given.13. In case <strong>of</strong> controlled goods by the Govt., the quotation must be sent subject to the prevailing conditionsregarding controlled goods. The price will be paid at the controlled rate or the price <strong>of</strong>fered by the firmwhich ever is less. In case <strong>of</strong> quotations <strong>of</strong> controlled goods, the controlled rates <strong>of</strong> the firm must beclearly mentioned in the quotations.14. (i) The tenderer shall supply the items in single batch only. At the time <strong>of</strong> supply the manufacturer orauthorised distributor will enclose original chemical analysis report on form 39 (which must mentionthe quantity <strong>of</strong> active ingredient) for each batch irrespective <strong>of</strong> quantity <strong>of</strong> drug supplied at each time.The chemical analysis report must be from the laboratory duly approved by the Govt. / State DrugController and the expenditure incurred shall be borne by the manufacturer / authorised distributor.(ii) List <strong>of</strong> Govt. approved analytical laboratories or the laboratories as approved by the State DrugController/Drug Controller <strong>of</strong> India, shall be obtained from the respective deptt. and be attached witheach supply as a pro<strong>of</strong> <strong>of</strong> its approval. If there is no Govt. approved lab, which has the facility to testthe drug, the firm must enclose a letter to the effect from State / Central Drug Controller at the time <strong>of</strong>supply <strong>of</strong> drug.(iii)(iv)Manufacturer’s own test report will be treated, merely as an additional documentary pro<strong>of</strong> for thequality <strong>of</strong> material against each supply made by the manufacturer / authorized distributor.In case <strong>of</strong> supply <strong>of</strong> medicines/drugs not manufactured in India, the sole distributors/marketing agentsin India are required to submit the Lab. Analytical Test Report <strong>of</strong> the Country <strong>of</strong> Origin along with thecertificate duly attested by the Drug Controller <strong>of</strong> India / State Drug Controller / Licensing Authorityregarding its permissibility and safe uses in India.(v) Guarantee / Warranty Certificate regarding assurance <strong>of</strong> the quality <strong>of</strong> material, under signature <strong>of</strong> themanufacturer / distributor for each batch should be submitted along with the items supplied. No supplywill be received without the Guarantee/Warranty Certificate and all other requisite documents at thetime <strong>of</strong> supply.(vi) The medicines / drugs supplied are also liable to be tested at random by chemical analysis from Govt.approved lab / Govt. testing lab without any intimation to the supplier. If the new test report iscontradictory with the test report submitted, the cost incurred on the whole process <strong>of</strong> testing shall bededucted from their previous due bills and this will be intimated to the supplier later on by the hospitaland / or process <strong>of</strong> recovery shall be started. Also, if at any stage <strong>of</strong> use the supplies are foundsubstandard, NO PAYMENT will be made for the entire rejected / substandard batch <strong>of</strong> that particularitem, even if the supplies have been consumed in good faith and the facts will be notified to the DrugController <strong>of</strong> India / State Drug Controller for taking necessary action.(vii) The Medical Superintendent <strong>of</strong> this hospital shall have power to relax Test Report in form 39 up to anorder value <strong>of</strong> Rs.15,000/-, but Tenderer shall have to provide manufacturer Test Report, undertakingand guarantee certificate at the time <strong>of</strong> supply.15. (i) If the firm fails to supply the items within the time mentioned in the supply order (unless permitted bythe hospital only in case <strong>of</strong> a request from the firm mentioning reasons acceptable to the hospital), thesupply order will stand cancelled without any notice at the risk and cost to the firm and that item shallbe procured from the next lowest approved firm (in short called L2). The difference in the cost, paid inextra, shall be deducted from the earlier dues, if any, and / or the firm will be asked to deposit thedifference in the amount in the hospital account so as to compensate for the extra cost borne by thehospital. On the second occasion again, if the firm does not supply, the Security Deposit will standforfeited and they shall not be allowed to participate in future open tender for a period <strong>of</strong> twoconsecutive years in this hospital. Punitive proceedings, as deemed fit, are also liable to be initiatedagainst that firm.(ii) All participating firms must submit an affidavit on non-judicial stamp paper stating that they or any <strong>of</strong>their products have neither been blacklisted nor debarred from participating in future tenders by anyState Government / Central Government organisations. If at any stage their claim turns out to be falsethe said firm will render itself liable for punitive action, as deemed fit. The present tender in which they


have quoted would be summarily rejected besides being debarred from participation in future opentenders for a period <strong>of</strong> two consecutive years.16.(i) In case <strong>of</strong> antibiotics, injections, biological preparations containing vitamins, enzymes and hormones,the supplies should not be beyond the expiry <strong>of</strong> 1/6 th shelf life at the time <strong>of</strong> receipt <strong>of</strong> the store.(ii) The stores tendered should strictly conform to the specifications mentioned, i.e. strength, formulae,quality, packing, etc.(iii) Pertaining to Blood Products, a certificate from an accredited laboratory, indicating that theformulation is free from HIV, HBV and HCV viruses must be furnished for each batch <strong>of</strong> productsupplied.17. Payment will be made only after the full and final supply <strong>of</strong> the stores, Lab. Analysis Report and theGuarantee/Warrantee Certificate for each batch. No payment on part supply will be made.18. Labels <strong>of</strong> all containers, cartons, wrappers, vials, strips etc. should invariably be marked in block letters“CENTRAL GOVT. SUPPLY NOT TO BE SOLD” with the indelible ink in RED COLOUR.19. (i) Quotations should be strictly according to the required specifications and in case <strong>of</strong> formulations,detailed formula along with the concerned literature be furnished with the name <strong>of</strong> manufacturer andthe brand under which the product is marketed should also be stated.(ii) All containers, i.e. bottles, tins, cartons, tubes etc. are required to be secured with pilfer pro<strong>of</strong> packingso as to ensure genuineness <strong>of</strong> the product packed and correctness <strong>of</strong> its contents and shall be neatlylabelled.(iii) Unutilized items will be notified by this hospital three months in advance to its expiry, and the sameshould be replaced free <strong>of</strong> cost by the tenderer / firm.20. All certificates as specified in the tender document should be in English language. Alternatively, atranslated copy in English (by an authorised translator), along with the original copy will be accepted.The translated copy should be duly certified / attested by the competent authority.21. (i) Canvassing <strong>of</strong> any sort or influencing the members <strong>of</strong> any committee involved in the purchase processat any stage shall be considered for disqualification <strong>of</strong> bid.(ii) All court cases will be settled in Delhi jurisdiction only.22. THE FOLLOWING DOCUMENTS SHOULD BE ATTACHED WITH TENDER DOCUMENT:(i)(ii)(iii)(iv)(v)Earnest Money Deposit for Rs.25,000/-A valid drug license / import License from the drug controller for the manufacture /Import <strong>of</strong> themedicine/drug quoted. If revalidation <strong>of</strong> drug license has been applied for the copy <strong>of</strong> application toState Drug / Licensing authority may be attached with a certificate that application for renewal wasmade within time frame as per Drug and Cosmetic Act as amended up to date and that has not beendeleted by licensing authorityValid DGQA certificates/Revised Schedule ‘M’/WHO-GMP certificates (item quoted to be highlightedclearly).Two years <strong>of</strong> manufacturing and marketing experience certificate for the specified product except incase <strong>of</strong> new drugsA copy <strong>of</strong> up-to-date returns/acknowledgement from the Department <strong>of</strong> Trade and Taxes with TIN NO.(vi) Certificate to the effect that all the terms and conditions mentioned in the tender document areacceptable.(vii) Latest Audited Balance Sheet <strong>of</strong> manufacturing firm (annual turnover for the last year).(viii) Latest certificate <strong>of</strong> authorisation from the manufacturer for the quoted drugs/medicines valid at leastfor one year.(ix)Latest Certificate regarding the blood products being free from HIV, HBV and HCV viruses from an


accredited laboratory(x)(xi)Undertaking from the firm to supply the quoted medicines/drugs within the stipulated time period.Affidavit on non-judicial stamp paper regarding the non blacklisting <strong>of</strong> the firm or any <strong>of</strong> its productsby any Central/State Govt organisation.(xii) Certificate issued by Central/State Drug Controller/Licensing Authority in case <strong>of</strong> newly introducedmedicines/drugs(xiii) S<strong>of</strong>t copy <strong>of</strong> the documents in the form <strong>of</strong> CD.(xiv)(xv)Undertaking to replace defective item(s) if any at the cost <strong>of</strong> supplier as per terms and conditionReceipt <strong>of</strong> purchase <strong>of</strong> tender document (for Rs.500/-)(xvi) Alphabetical Index <strong>of</strong> drugs quoted in the present tender together with page no.(s) <strong>of</strong> Drug Licence,Schedule M or WHO GMP Certificate and marketing & manufacturing certificates.23. The Competent authority reserves the right to reject the tender at any stage if any discrepancy ordeficiency is found in the tender process.24. Each page <strong>of</strong> the terms and conditions to be signed by the authorised signatory with <strong>of</strong>ficial seal <strong>of</strong> thefirm and attached with the bids.************


Group I (Miscellaneous Drugs)Sn Item Name <strong>of</strong> Medicine Pack SJHrequirement1 Cream Betamethasone Dipropionate 0.05% 15 gm. Tube2 Cream Betamethasone Dipropionate 0.25% + Clotrimazole 1% 15 gm. TubeRMLrequirement3 Cream Betamethasone Valerate 0.1% 15 gm. Tube 15,000 15,0004 Cream Betamethasone Valerate 0.12% + Neomycin Sulphate 0.5% 15 gm. Tube 15,0005 Cream Choloroxylenol 1.4%, Terpineol 2.7% 1006 Cream Clobetasol 17 butyrate 0.05% 10 gm. Tube7 Cream Clobetasol Propionate 0.05% 10 gm. Tube8 Cream Clotrimazol 1% 15 gm. Tube 10,000 2,0009 Cream Estriol 15 gm. Tube 510 Cream Eututic Mixture <strong>of</strong> Local Anaesthatics Prilociane + Xylocaine 15 gm. Tubes11 Cream Fluticasone 10 gm. Tube12 Cream Framycetin Sulph. 1% 20 gm Tube 15,000 5,00013 Cream Framycetin Sulph. 1% 100 gm Tube 10,000 1,50014 Cream Fucidic Acid 20 mg. / Gm. 5 gm. Tube 2,00015 Cream Fucidic Acid 20 mg./gm. + Betamethasone Valerate 1 mg./gm. 5/10gm Tube 1,50016 Cream Heparin 50 IU, Benzyl Nicotinate 2 mg / 1 gm 20gm. Tube 5,000 5,00017 Cream Miconazole 2% 15 gm. Tube18 Cream Nadifloxacin 1% Cream 10 gm &100 gm Tube/Jar 2,00019 Cream Permethrin 5% 30 gm. Tube20 Cream Zinc oxide Tube21 Ear Drops Chloramphenicol 5 ml Vial22 Ear Drops Clotrimazole 1% 10 ml. Vial 20023 Ear Drops Paradichlorobenzone 2% + Benzocaine 2.7% +Chlorambutol 5% + Terpentine Oil 15% w/v24 Ear Drops Prednisolone 0.5% Chloramphemicol 5%, LignocaineHCL 2% Acetic acid 2%10 ml. Vial5 ml Vial25 Ear Drops Waxsol / Soliwax 10 ml. Bottle 3,50026 Eye / EarDrops27 Eye / EarDrops28 Eye / EarDrops29 Eye / EarDrops30 Eye / EarDrops31 Eye / EarDrops32 EyeapplicapBetamethasone Sod. Phos. 0.1%5 ml. VialBetamethasone Sod. Phos. 0.1% + Neomycin Sulphate 5 ml. Vial0.5%Cipr<strong>of</strong>loxacin 0.3% w/v 5 ml Vial 20,000 4,000Gentamycin 0.3% + Hydrocortisone accetate 1%5 ml VialGentamycin 0.3% w/v 5 ml Vial 1,500 1,500Norfloxacin eye/ear 0.3% w/v5 ml VialChloramphenicol opth. 50 / 100 Nos 22,000 10,00033 Eye Drops Acyclovir 3% Vial34 Eye Drops Aomide 2% 5 ml. Vial35 Eye Drops Apraclonidine 1% 5 ml. Vial36 Eye Drops Atropine 1% w/v 5 ml. Vial 50037 Eye Drops Bimatoprost 0.03% 5 ml. Vial 5,00038 Eye Drops Brimonidine 0.15% 5 ml. Vial 5,00039 Eye Drops Brimonidine 0.2% 5 ml. Vial 5,00040 Eye Drops Bromfenac 0.09% 5 ml. Vial 5,0001.


Group I (Miscellaneous Drugs)Sn Item Name <strong>of</strong> Medicine Pack SJHrequirement41 Eye Drops Carboxymethyl Cellulose 0.5% 10 ml Vial 20,00042 Eye Drops Chloramphenicol 5 ml Vial43 Eye Drops Cipr<strong>of</strong>loxacin + Dexamethasone 5 ml Vial44 Eye Drops Clotrimazole 1% 5 ml Vial45 Eye Drops Cyclopentolate 1% W/V 5 ml. Vial 55046 Eye Drops Cycomide 1 % 5 ml. Vial47 Eye Drops Dexamethasone 0.1% + Chloramphenicol 0.5% 5 ml. Vial48 Eye Drops Dicl<strong>of</strong>enac Sodium 0.1% w/v 5 ml. Vial49 Eye Drops Dorzolamide 0.5% 5 ml. Vial50 Eye Drops Flucomethadone + Tobramycin 5 ml. Vial51 Eye Drops Fluconazole 5 ml. Vial52 Eye Drops Fluorometholone 0.1% 5 ml Vial 5,000RMLrequirement53 Eye Drops Flurbipr<strong>of</strong>en Sodium 0.03% 5 ml Vial 1,000 20054 Eye Drops Framycetin Sulp. 0.5% 5 ml Vial55 Eye Drops Furipid 5 ml Vial 1,00056 Eye Drops Gatifloxacin 0.3% 5 ml Vial 10,00057 Eye Drops Homoatropine hydrobromide 2% 5 ml. Vial 1,000 20058 Eye Drops Hydroxypropyl methyl cellulose 0.3% w/v 10 ml Vial 10,00059 Eye Drops Hyper Mellose 0.5% 10 ml Vial60 Eye Drops Hypertonic saline (3%) 100 ml Bottle 2061 Eye Drops ketorolac Tromethamine 0.5% 5 ml Vial 2,00062 Eye Drops Ketotifen Fumarate 5 ml Vial63 Eye Drops Lanatoprost (0.005%) 2.5 ml Vial 5,00064 Eye Drops Moxifloxacin 0.5% 5 ml Vial 10,20065 Eye Drops Moxifloxacin 0.5% + Dexamethasone 0.1% 10 ml Vial 20,00066 Eye Drops Moxifloxacin 0.5% + Ketorolac 0.3% 10 ml Vial 3,00067 Eye Drops Moxifloxacin 0.5% + Prednisolone Acetate 1% 5 ml Vial 20,00068 Eye Drops Mythyl Cellulose 2% 5 ml. vial 3,00069 Eye Drops Naphazoline 0.05% w/v 5 ml. vial 15,00070 Eye Drops Nephazoline 0.5% + Chlorpheniramine 0.1% + Boric 5 ml VialAcid 0.1%71 Eye Drops Netamycin 5% Vial 1,00072 Eye Drops Ofloxacin 0.3 % 5 ml Vial73 Eye Drops Ofloxacin 0.3% + Dexamethasone 0.01% 5 ml Vial74 Eye Drops Oloptadine 0.1% 5 ml Vial 2,00075 Eye Drops Paracaine Vial76 Eye Drops Phenyephrine 0.12% + Naphazoline 0.05% 10 ml. vial77 Eye Drops Phenyl Epinephrine 10% 5 ml Vial 50078 Eye Drops Pilocarpine Nitrate 2% 5 ml Vial 20079 Eye Drops Pilocarpine nitrate 4% 5 ml Vial80 Eye Drops Polyvenyl Alcohal + Povidone ( Tear Substitute ) 5 ml Vial81 Eye Drops Prednisolone Acetate 01% 5 ml Vial 12,00082 Eye Drops Proparacaine 2% 5 ml Vial 1,10083 Eye Drops Sod. Sulphacatamide 20% 10 ml Bottle 300 25084 Eye Drops Sodium Chloride 5% 10 ml Vial85 Eye Drops Timolol Maleate 0.5% 5 ml. Vial 20,0002.


Group I (Miscellaneous Drugs)Sn Item Name <strong>of</strong> Medicine Pack SJHrequirement86 Eye Drops Tobramicin 0.3% 5 ml Vial 5,20087 Eye Drops Travoprost 0.004% Vial 5,00088 Eye Drops Tropicamide 0.8% 5 ml. VialRMLrequirement89 Eye Drops Tropicamide 0.8% + Phenylephrine HCL 5% 5 ml. Vial 21,500 50090 Eye Drops Tropicamide 1% 5 ml. Vial 20091 Eye Oint Atropine Sulph.1% 3 gm Tube92 Eye Oint Cipr<strong>of</strong>loxacin 0.3% 5 gm. Tube 2,15093 Eye Oint Framycetin Sulph. 0.5% Tube 25094 Eye Oint Hypersol-6 (5% sodium chloride) 3 gm. Tube 10,00095 Eye Oint Ketoconazole 2% W/V Tube96 Eye Oint Moxifloxacin Tube 1,25097 Eye Oint Natamycin 5% 3ml Vial98 Eye Oint Polymyxin B Sulphate 10,000 IU + Bacitracin zinc 400IU per gm.99 Eye Oint Polymyxin B- Sulpt. 5000 I.U. + Neomycin Sulph.3400I.U. + Zine Bacitracin 400 I.U. per gm.5 gm Tube5 gm Tube 5,000 5,000100 Eye Oint Sodium Chloride 6% 3 gm.Tube 600101 Eye Oint Tobramicin 0.3% + Dexamethasone 0.01% 5 gm. Tube 600102 Eye Oint Tobramycin 5 gm. Tube 5,150103 Eye strips Fluoroscein 4% strips Box <strong>of</strong> 100 36104 Eye strips Schirmer's Strips Box <strong>of</strong> 100 2105 Eye strips Sodi. Fluolrescent Strip 2% Box106 For Enema Glycerine Enema 100 ml Pouch107 For Enema Sod. Phosphate 6% W/V, Sod. Acid Phosphate 16% W/V 100 mlEnema108 For Enema S<strong>of</strong>t Soap for Enema 5 kg. Jar109 Gel Benzocaine gel 20% Tube110 Gel Chlorhxidine Gluconate Gel 10% 10 gm. Tube111 Gel Dicl<strong>of</strong>enac Analgesic topical gel 15 gm. Tube112 Gel Dicl<strong>of</strong>enac Diethyl Ammonium Gel 30 gm. Tube 2,000113 Gel Ketoconazole Oral Gel 0.1% Vial114 Jelly Electro Jelly 100 ml Bottle115 Jelly Lignocain Jelly 2% 30 gm. Tube 12,000 12,000116 Jelly Synthetic & Vegetable Gum Jelly 50 gm. Tube117 Jelly Vaseline (White s<strong>of</strong>t Paraffin) 25/50 Kg Pack 2,000 300118 Liquid Anesthetic Ether 500 ml Bottle 200119 Liquid Distil Water 5 Liter 10,000 1,000120 Liquid Distil Water 25 Liter 10,000121 Liquid Glycerine Pure 25 / 50 Kg. 500 300122 Liquid Hydrogen Peroxide (20 Volume) 500 ml Bottle 3,000123 Liquid Lactulose 667 mg/ ml Liquid 200ml Bottle 1,000 4,000124 Liquid Liquid Paraffin (heavy) 100 / 500 ml.Bottle125 Liquid Peritoneal Dialysis Fluid 1 Lit. Bottle 3,0003.


Group I (Miscellaneous Drugs)Sn Item Name <strong>of</strong> Medicine Pack SJHrequirement126 Liquid Trichloric Acetic Acid 500 ml Bottle127 Lotion Carbolic Acid 500 gm Bottle 1,000RMLrequirement128 Lotion Choline Salicylate 9% + Benzalkorium Chloride 0.2% w/v 15 gm. Bottle129 Lotion Clotrimazole Lotion 15 ml. Bottle 800130 Lotion G.B.H.C. Lotion 100 ml Bottle 2,000 1,000131 Lotion Gention Violet 0.25% Lotion / mouth paint 30 ml. Bottle132 Lotion Gention Violet 0.5% Lotion / mouth paint 30 ml. Bottle133 Lotion Gention Violet 2% Lotion / mouth paint 30 ml. Bottle134 Lotion Permethrin Lotion 5% 50 ml. Vial135 Lotion Podophyline Lotion 25% 10 ml pack Vial136 Mouth Wash Chlorhexidine Bottle137 Mouth Wash Chlorhexidine Gluconate 0.2% + Sodium Fluoride0.05% + Zinc Chloride 0.09%150 ml Bottle138 Mouth Wash Povidone Iodine 100 ml Bottle139 Nasal Drops Glucose Glycerin 10 ml. Vial140 Nasal Drops Oxymetazoline HCL 0.05% Sol 10 ml Bottle141 Nasal Drops Oxymetazoline HCL 1% Sol. 10 ml Bottle 1,000 1,000142 Nasal Drops Saline Nasal Drops (Buffered) 0.9% Vial 1,000143 Nasal Drops Xylometazolin HCL 0.05% Sol. 10 ml. Vial 2,000144 Nasal Drops Xylometazoline 1% 10 ml. Vial145 Nasal Spray Desmopression nasal spray Pack146 Nasal Spray Midazolam Nasal Spray 5mg / ml Bottle 100147 Nebu. Solu. Budesomide 2.5 ml. Amp.148 Nebu. Solu. Budesonide nebuliser Solution 0.25 mg./ml., 0.5 mg./ml. 2 ml. repsule 100149 Nebu. Solu. Ipratropium Bromide 2.5 ml. Amp. 200 5,500150 Nebu. Solu. Levo-salbutamol 0.63 mg. / ml. Amp. / Bottle 20,000151 Nebu. Solu. mesna 600 mg./3 ml. 3 ml. Amp. 500152 Nebu. Solu. Salbutamol 5 mg/ml 15 ml Bottle 5,000 10,000153 Nebu. Solu. Terbutaline 1.5 mg. / ml. Amp. / Bottle154 Nebu. Solu. Tobramycin for inhalation use 5 ml. Amp./Vial155 Oil Castor Oil 25 ml Bottle156 Oil Turpentine Oil 5 Lit. Can 3,000 80157 Oil Turpentine Oil 25 Lit. Can 3,000158 Oint. Betametasone Valerate .05% + Phenyl Ephrine Hcl .1% 15 gm. Tube+ Lignocaine Hcl 2.5% Oint159 Oint. Glycerin Mag. Sulph. 100 gm. Jar160 Oint. Lignocain Oint. 5% 35 gm Tube161 Oint. Nitr<strong>of</strong>urazone 0.2% w/w 500 gm. Jar162 Oint. Polymyxin B- Sulpt. 5000 I.U. + Neomycin Sulph.3400 15 gm. Tube 25,000 1,000I.U. + Zine Bacitracin 400 I.U.+ Hydrocortisone10mg/gm Skin Oint163 Oint. Povidone Iodine Oint 5% 250 gm. Jar 900164 Oint. Povidone Iodine Oint 5% 500 gm. Jar165 Oint. Povidone Iodine Oint 5% 15 gm. Tube 3,000166 Oint. Salicylic Acid 6% Oint Tube167 Oint./Gel Acyclovir 5% (5 gm Tube) 5 gm. Tube168 Oint./Gel Mupirocin 2% w/w 5 gm. Tube 1,000169 Oint./Gel Salicylic Acid 3% + Liq Picis carb. 6% 20 /50 gm. pack170 Oint./Gel Triamcinolone Acetonide 0.1% 15 gm Tube4.


Group I (Miscellaneous Drugs)Sn Item Name <strong>of</strong> Medicine Pack SJHrequirement171 Paint Aluminum paint Bottle172 Paint Boroglycerine Paint 5 ml Bottle173 Paint Clotrimazole mouth paint 1% 15 ml. 500174 Paint Clotrimazole mouth paint 1% 30 ml. 500RMLrequirement175 Paint Gum Paint 15 ml. Vial 4,500176 Paint Mandles Throat Paint 10 ml. Vial177 Paste Alveogyl Alveolor paste 30gm Bottle178 Paste Toothpaste containing Potassium nitrate 5% + SodiumMon<strong>of</strong>luorophosphate 0.7%100 gm. Tube179 Pessary Clotrimazole veg pessary Nos. 1,000180 Pessary Nystatin Vag. Pessary lLac Unit Nos.181 Pessary Povidone Iodine 200mg vaginal passery Nos.182 Powder Acraflavin powder 30gm Bottle183 Powder Ammonium Bicarbonate 500 gm Pack184 Powder Bleaching powder 25 Kg Bag185 Powder Dextrose Monohydrate Powder 500 gm Pack 115186 Powder French Chalk Powder (Purified Talc) 50 kg. Bag 50 kg Bag187 Powder L-glutamine granules for use in critical illness 150 gm Jar 500188 Powder Low osmolarity ORS pkt. With Na 75 mmol/L, CL65mmol/L, K 20mmol/L after reconstitution.35 gm Sachet189 Powder Mercurochrome powder 30 gm Pack 100190 Powder O.R.S. (W.H.O. Formula) 20.5 gm Pack 1.5 lac 50,000191 Powder Plaster <strong>of</strong> Paris (25/50 kg Drum or airtight Bag) Drum/Bag 15,000192 Powder Polymyxin B- Sulpt. 5000 I.U. + Neomycin Sulph.3400I.U. + Zine Bacitracin 400 I.U. per gm10 gm Bottle 2,500193 Powder Pot.Permanganate 500 gm Pack 30 k.g 25194 Powder Salicylic acid powder 500 gm pack 30195 Powder Soda bi carb powder 500 gm pack 30196 Powder Soda Lime 5 kg. Jar 400197 Powder Vit. D Cholicalciferol Sachet 50,000198 Soloution Caffine Citrate Oral Solution Bottle 400199 Soloution Icthamol Glycerine 10% Ear Pack 10 ml Bottle200 Soloution Polyvinyl Polymer 2.52%, Benzocain 0.036% Propellar 70% Bottle 100201 Soloution Super oxide Solution Bottle202 Soloution Tannic acid 2% + Zinc Chloride 1% + Cetrimide 0.1%gum astringent203 Soloution Tincture Benzoin Bottle 50Bottle204 Soloution Tincture iodine Bottle205 Soloution Vitamin A Solution 1 lac unit/ml, 50,000 I.U. /ml, 100 / 60 ml10100ml/60mlBottle206 Solution Calcium Phosphate + Disodium Phosphate Soln. 5,10gm Vial207 Solution Cetrimide soln. (5%) Bottle208 Solution Eusol 500 ml Bottle 120209 Supp. Bisacodyl Suppositories Nos.210 Supp. Dicl<strong>of</strong>enac 100 mg Suppositories Nos.5.


Group I (Miscellaneous Drugs)Sn Item Name <strong>of</strong> Medicine Pack SJHrequirement211 Supp. Glycerine Suppositories Adult Size Nos. 3,000212 Supp. Glycerine Suppositories Child Size Nos. 200213 Supp. Paracetamol Suppositories 80mg & 120mg & 250mg Nos.214 Susp. Albendazole 200 mg Per 5ml Suspension 10 ml Bottle 500RMLrequirement215 Susp. Antacid Gel ( Alumia 250mg + Magnesia 250mg / 5ml ) 170 ml Bottle 10,000 10,000216 Susp. Ibupr<strong>of</strong>en 100 mg /5 ml Suspension 60 ml Bottle 50217 Susp. Metronidazole 100 mg / 5 ml Suspension. 100 ml Bottle 500 200218 Susp. Posaconazole (40 mg. / ml.) Oral Suspension Bottle 50219 Susp. Sodium Citrate Suspension 30 ml. Bottle220 Swabs Alcohol Swabs for skin disinfectant Pack <strong>of</strong> 100221 Syrup Activated demethicone 40mg + Dicyclomine HCL 10mg. Per ml. 10 ml. Bottle10 ml. Bottle222 Syrup Ambroxol Hcl 30 mg and Salbutamol 1mg Per 15ml. 15 ml. Bottle 1,000223 Syrup Calcium with Magnesium equivalent to 250 mgelementary calcium/ 5 ml.224 Syrup Carbamazepine l00 mg / 5 ml 60 ml Bottle200 ml Bottle 5,000225 Syrup Cetrizine 5 mg / 5ml 60 ml Bottle 3,000226 Syrup Chloral Hydrate Syrup Bottle227 Syrup Chloroquine Phosphate 50 mg / 5 ml 30 ml Bottle 200 300228 Syrup Cough Exp. Syrup (Combination <strong>of</strong> Antihistamine,Ammonium Chloride Sod.Citrate, Menthol)229 Syrup Cough Sedative Syrup (Combination <strong>of</strong> Antihistamine,Codeine, Ephedrine HCL)200 ml Bottle 20,000 9,000200 ml Bottle 500 10,000230 Syrup Cyproheptadine Syrup 2 mg per 5 ml 200 ml Bottle 700231 Syrup Diazepam Syrup 2mg/ 5ml 60 ml Bottle 500232 Syrup Digoxin Drops 0.03 mg. / ml. 30 ml Bottle 1,000233 Syrup Disodium Hydrogen Citrate Syrup 1.38 gm per 5ml 100 ml Bottle 200234 Syrup Domperidone Syrup 1 mg./ml. 30 ml Bottle 1,500235 Syrup Etophylline 46.5mg + Theophylline Syrup 14mg Per 5ml 100 ml Bottle 1,000236 Syrup Ferrous ascorbate or Carbonyl iron Syrup givingelemental iron in the range <strong>of</strong> 30-50 mg. , folic acid500 mcg. Per 5 ml.Bottle237 Syrup Glycrol Oral Syrup 100 gm Bottle238 Syrup Iron Syrup containing Colloidal Iron Hydrox 500 mg + 200 ml Bottle 3,600Folic Acid 500 mcg + Vit. B-12 5 mcg. Per 5 ml.239 Syrup Iron Syrup Containing Ferrous Ascorbate 30 mg and 15 ml Bottle 500Folic Acid 500mcg in each 5 ml.240 Syrup Levo Salbutamol 1 mg/ml Syrup 60ml Bottle241 Syrup Linctus codine Phosphate 210 ml Bottle242 Syrup Metaclopromide Syrup 5 mg per 5 ml 30 ml Bottle 50243 Syrup Milk <strong>of</strong> magnesia 11.5 ml + liquid Paraffin 3.75 ml 170 ml Bottle 1,000 2,500per 15 ml244 Syrup Multi Vitamin 100 ml Bottle 11,000245 Syrup Multivitamin Drops 15 ml Bottle 2,000 5006.


Group I (Miscellaneous Drugs)Sn Item Name <strong>of</strong> Medicine Pack SJHrequirement246 Syrup Nimuslide 50mg./5ml 60 ml BottleRMLrequirement247 Syrup Paracetamol 125mg / 5ml. 60 ml Bottle 12,000 2,100248 Syrup Phenytoin Sodium 100 mg. / 5 ml. 100 ml Bottle 200249 Syrup Piperazine Citrate 750mg/5ml. Bottle250 Syrup Pot.Chloride 500mg/ 5ml. Syrup 200 ml Bottle 2,000 2,300251 Syrup Prednisolone 5 mg/5 ml, 15 mg/5 ml Syrup 60 ml Bottle252 Syrup Promethazine HCL (5mg/5ml) Syrup 100 ml Bottle 3,000 1,000253 Syrup Resperidone 1mg/1ml Syrup 60 ml Bottle254 Syrup Salbutamol 2mg./5ml Syrup 100 ml Bottle 5,000 1,000255 Syrup Sodium Picosulphate + Liquid Paraffin + MagmisiumHydroxide200 ml Bottle256 Syrup Sucralfate 1gm + Oxetacaine 20mg syrup / 5 ml 100 ml Bottle257 Syrup Tricholine Citrate 0.55mg / 5ml Syrup 100 ml Bottle258 Syrup Tricl<strong>of</strong>os Sod. 500 mg. / ml. Syrup 30 ml Bottle 1,000 50259 Syrup Trimeprazine Tartrate 30mg./5ml Syrup 60 ml Bottle260 Syrup Vitamin B-Complex Syrup 200 ml Bottle 20,000 4,000261 Syrup Zinc Acetate Syrup 20mg. elemental Zinc in 5ml 100 ml Bottle 507.Two Hundred Sixty One Items

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!